Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE0GK
|
||||
| Drug Name |
benzyl (2S,3S)-1-(cyanomethylamino)-3-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL382971
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H21N3O3
|
||||
| Canonical SMILES |
CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)NCC#N
|
||||
| InChI |
InChI=1S/C16H21N3O3/c1-3-12(2)14(15(20)18-10-9-17)19-16(21)22-11-13-7-5-4-6-8-13/h4-8,12,14H,3,10-11H2,1-2H3,(H,18,20)(H,19,21)/t12-,14-/m0/s1
|
||||
| InChIKey |
JDHIDTYIXYVCAE-JSGCOSHPSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.